Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges.
Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges.
复制标题
DOI:
10.3390/ijms24054778
复制
发表时间:
2023-03-01
影响因子:
5.6
通讯作者:
中科院分区:
文献类型:
--
作者:
The advancement in epigenetics research over the past several decades has led to the potential application of epigenome-editing technologies for the treatment of various diseases. In particular, epigenome editing is potentially useful in the treatment of genetic and other related diseases, including rare imprinted diseases, as it can regulate the expression of the epigenome of the target region, and thereby the causative gene, with minimal or no modification of the genomic DNA. Various efforts are underway to successfully apply epigenome editing in vivo, such as improving target specificity, enzymatic activity, and drug delivery for the development of reliable therapeutics. In this review, we introduce the latest findings, summarize the current limitations and future challenges in the practical application of epigenome editing for disease therapy, and introduce important factors to consider, such as chromatin plasticity, for a more effective epigenome editing-based therapy.
登录
查看更多内容
影响因子:
48
作者:
Chavez A;Tuttle M;Pruitt BW;Ewen-Campen B;Chari R;Ter-Ovanesyan D;Haque SJ;Cecchi RJ;Kowal EJK;Buchthal J;Housden BE;Perrimon N;Collins JJ;Church G
通讯作者:
Church G
DOI:
10.1016/j.omtm.2020.09.001
发表时间:
2020-12-11
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
作者:
Backstrom JR;Sheng J;Wang MC;Bernardo-Colón A;Rex TS
通讯作者:
Rex TS
影响因子:
16.6
作者:
Braun SMG;Kirkland JG;Chory EJ;Husmann D;Calarco JP;Crabtree GR
通讯作者:
Crabtree GR
影响因子:
12.6
作者:
Aguiar S;van der Gaag B;Cortese FAB
通讯作者:
Cortese FAB
影响因子:
8
作者:
Amina SJ;Guo B
通讯作者:
Guo B